Kasan Insight :: Korea IP Law Blog

Many generic drug companies challenged the validity of PTEs on period and the protection scope of extended patent rights. The first i...

In pharmaceutical industry, data exclusivity (DE) protection is an important IP right. DE is to protect the value of extensive pre-clinical...

Background   The patent term extension system was first introduced in Korea on July 1, 1987. Under the 1987 Act, a petition for pat...

KFTC’s decision or order does not become effective until the formal written decision and order has been issued. Following receipt of the KF...

The Seoul High Court denied the Qualcomm’s petition to stay the order of the Korea Fair Trade Commission (KFTC). The court found that c...